Susquehanna International Group, LLP Nova Bay Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$0.73 - $1.43 $44,021 - $86,233	-60,303 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.52 - $0.81 $31,357 - $48,845	60,303 New	60,303 $42,000
Q3 2020 Nov 16, 2020	SELL	$0.72 - $1.61 $39,741 - $88,867	-55,197 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.71 - $1.29 $611 - $1,110	861 Added 1.58%	55,197 $63,000
Q1 2020 May 15, 2020	BUY	$0.29 - $1.5 $15,757 - $81,504	54,336 New	54,336 $33,000
Q3 2019 Nov 14, 2019	SELL	$0.45 - $1.73 $5,413 - $20,811	-12,030 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.28 - $3.1 $20 - $229	-74 Reduced 0.61%	12,030 $20,000
Q1 2019 May 15, 2019	BUY	$0.91 - $1.97 $11,014 - $23,844	12,104 New	12,104 $15,000
Q3 2018 Nov 14, 2018	SELL	$1.3 - $2.52 $15,527 - $30,098	-11,944 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.2 - $3.5 $26,276 - $41,804	11,944 New	11,944 $30,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $42.2M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.